New
Novo Integrated Sciences Faces Delisting From Nasdaqon November 4, 2024, Novo Integrated Sciences, Inc. (nasdaq: Nvos) Received Notification From The Nasdaq Stock Market Llc That Its Common Stock Is Set To Be Delisted From Nasdaq. The Tradi
This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Novo Integrated Sciences’s 8K filing here.
Novo Integrated Sciences Company Profile
Novo Integrated Sciences, Inc, together with its subsidiaries, provides multidisciplinary primary care and related wellness products and services in Canada. It operates through two segments, Healthcare Services and Product Sales. The company offers physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, concussion management and baseline testing, trauma sensitive yoga and meditation for concussion-acquired brain injury and occupational stress-PTSD, women’s pelvic health program, sports medicine therapy, assistive devices, dietitian, holistic nutrition, fall prevention education, sports team conditioning program, and private personal training services.
Featured Stories
- Five stocks we like better than Novo Integrated Sciences
- What Makes a Stock a Good Dividend Stock?
- Macro Headwinds Send Microchip Technology Stock to the Buy Zone
- Short Selling: How to Short a Stock
- 3 Rising-Margin Stocks with Strong Growth Potential
- Insider Trades May Not Tell You What You Think
- 3 Recession-Resistant Stocks: Low Beta, High Margins, Low Debt
